MicroRNA-34a regulates cardiac ageing and function.
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Ageing is the predominant risk factor for cardiovascular diseases and contributes to a significantly worse outcome in patients with acute myocardial infarction. MicroRNAs (miRNAs) have emerged as crucial regulators of cardiovascular function and some miRNAs have key roles in ageing. We propose that altered expression of miRNAs in the heart during ageing contributes to the age-dependent decline in cardiac function. Here we show that miR-34a is induced in the ageing heart and that in vivo silencing or genetic deletion of miR-34a reduces age-associated cardiomyocyte cell death. Moreover, miR-34a inhibition reduces cell death and fibrosis following acute myocardial infarction and improves recovery of myocardial function. Mechanistically, we identified PNUTS (also known as PPP1R10) as a novel direct miR-34a target, which reduces telomere shortening, DNA damage responses and cardiomyocyte apoptosis, and improves functional recovery after acute myocardial infarction. Together, these results identify age-induced expression of miR-34a and inhibition of its target PNUTS as a key mechanism that regulates cardiac contractile function during ageing and after acute myocardial infarction, by inducing DNA damage responses and telomere attrition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“miR 124, miR-34a/b/c, and miR-29a/b/c are upregulated in response to p53 activation and facilitate cellular senescence by downregulating survival and cell proliferation factors (Hermeking, 2010; Boon et al., 2013; Hu et al., 2014; Xu S. et al., 2019).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Boon et al., 2013
Citations
Cites
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Telomere measurement by quantitative PCR
Cawthon, R. M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.10.e47 · Cited by 3,487
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
Identifying differentially expressed genes using false discovery rate controlling procedures
Reiner, A., Yekutieli, D., & Benjamini, Y. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btf877 · Cited by 1,765
miR-34a repression of SIRT1 regulates apoptosis
Yamakuchi, M., Ferlito, M., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801613105 · Cited by 1,342
Telomere dysfunction induces metabolic and mitochondrial compromise
Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F. L., Guo, M., Cooper, M., Kotton, D., Fabian, A. J., Walkey, C., et al. (2011) · Nature · doi:10.1038/nature09787 · Cited by 1,319
MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
Bonauer, A., Carmona, G., Iwasaki, M., Mione, M., Koyanagi, M., Fischer, A., Burchfield, J., Fox, H., Doebele, C., Ohtani, K., et al. (2009) · Science · doi:10.1126/science.1174381 · Cited by 1,215
Self-citationPervasive roles of microRNAs in cardiovascular biology
Small, E. M., & Olson, E. N. (2011) · Nature · doi:10.1038/nature09783 · Cited by 1,180
Cited by
Items 201–300 of 828
Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy
Ni, T., Lin, N., Lu, W., Sun, Z., Lin, H. M., Chi, J., & Guo, H. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-06968-0 · Cited by 69
“Indeed, previous studies have demonstrated that diabetes induces the activation of pro-aging miR-34a in the heart [39], microRNA-34a promotes cardiac aging and dysfunction [40], miR-34a over-expression induces age-related vascular diseases [41], and miR-34a down-regulation alleviates early diabetic nephropathy [42].”
BackgroundmiR-34a promotes fibrosis in aged lungs by inducing alveolarepithelial dysfunctions
Cui, H., Ge, J., Xie, N., Banerjee, S., Zhou, Y., Liu, R.-M., Thannickal, V. J., & Liu, G. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00335.2016 · Cited by 66
“To determine the role of miRNAs in the pathogenesis of pulmonary fibrosis in the aged population, we initially focused on miR-34a primarily due to its well-established role in cellular senescence and aging (4, 9, 38, 44).”
BackgroundSmall molecules, big effects: the role of microRNAs in regulation of cardiomyocyte death
Skommer, J., Rana, I., Marques, F. Z., Zhu, W., Du, Z., & Charchar, F. J. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.287 · Cited by 67
“Recent studies identified that genetic deletion of aging-associated miR-34a reduces cardiomyocyte cell death and improves functional recovery after MI, which is attributed to the function of a novel miR-34a target gene, PNUTS.125 One of the cellular effects of Pnuts protein is nuclear sequestration of Pten,126 a negat…”
BackgroundInfluentialCostantino, S., Paneni, F., Mitchell, K. J., Mohammed, S. A., Hussain, S., Gkolfos, C., Berrino, L., Volpe, M., Schwarzwald, C. C., Lüscher, T. F., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.04.082 · Cited by 68
Clinical Significance of MicroRNAs, Long Non-Coding RNAs, and CircRNAs in Cardiovascular Diseases
Singh, D. D., Kim, Y., Choi, S. A., Han, I., & Yadav, D. K. (2023) · Cells · doi:10.3390/cells12121629 · Cited by 67
PNUTS/PP1 Regulates RNAPII-Mediated Gene Expression and Is Necessary for Developmental Growth
Ciurciu, A., Duncalf, L., Jonchère, V., Lansdale, N., Vasieva, O., Glenday, P., Rudenko, A., Vissi, E., Cobbe, N., Alphey, L., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003885 · Cited by 69
“These roles may be especially important during ageing since loss of PNUTS expression is associated with an agedependent increase in cardiomyocyte apoptosis and decline in cardiac function [33].”
BackgroundRole of microRNAs in Alcohol-Induced Multi-Organ Injury
Natarajan, S. K., Pachunka, J., & Mott, J. L. (2015) · Biomolecules · doi:10.3390/biom5043309 · Cited by 67
“shown to be upregulated in the aged heart, contributing to cardiomyocyte cell death which results in an age-related decrease in cardiac function [169].”
BackgroundMills, J. D., Iyer, A. M., van Scheppingen, J., Bongaarts, A., Anink, J. J., Janssen, B., Zimmer, T. S., Spliet, W. G., van Rijen, P. C., Jansen, F. E., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06145-8 · Cited by 62
TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis
Park, C. H., & Yoo, T. (2022) · Pharmaceuticals · doi:10.3390/ph15121485 · Cited by 68
The Role and Molecular Mechanism of Non-Coding RNAs in Pathological Cardiac Remodeling
Gao, J., Xu, W., Wang, J., Wang, K., & Li, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030608 · Cited by 64
Lnc ing Epigenetic Control of Transcription to Cardiovascular Development and Disease
Rizki, G., & Boyer, L. A. (2015) · Circulation Research · doi:10.1161/circresaha.117.304156 · Cited by 63
“eration? miRNAs have been shown to be involved in cardiac aging.(147,148) Do lncRNAs similarly play a part in the aging”
BackgroundCRISPR-Mediated Activation of Endogenous Gene Expression in the Postnatal Heart
Schoger, E., Carroll, K. J., Iyer, L. M., McAnally, J., Tan, W. H., Liu, N., Noack, C., Shomroni, O., Salinas, G., Groß, J., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.314522 · Cited by 60
MicroRNAs in Stem Cell Function and Regenerative Therapy of the Heart
Seeger, F. H., Zeiher, A. M., & Dimmeler, S. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.300138 · Cited by 59
“In addition, the protein phosphatase 1 regulator PNUTS (or serine/threonineprotein phosphatase 1 regulatory subunit 10 [PPP1R10]), a protein involved in DNA damage response and telomere shortening, is repressed by miR-34 (Figures 1 and 2).(52,54) Among the miRNAs that are upregulated after cardiac stress, miR-214 exhi…”
BackgroundSelf-citationWhat have we learned on aging from omics studies?
Cellerino, A., & Ori, A. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.06.012 · Cited by 61
Su, G., Sun, G., Liu, H., Shu, L., & Liang, Z. (2018) · Heart and Vessels · doi:10.1007/s00380-018-1169-6 · Cited by 59
Bär, C., Chatterjee, S., Falcão‐Pires, I., Gonçalves‐Rodrigues, P., Sluijter, J. P. G., Boon, R. A., Nevado, R. M., Andrés, V., Sansonetti, M., Windt, L. J. D., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa195 · Cited by 62
“more important for miR-34-induced cardiac aging than SIRT1, although the role of PNUTS in endothelial aging is currently unknown.(187) The Non-coding RNAs: mechanisms and therapeutic targets 1813”
BackgroundSelf-citationDual 3D DNA Nanomachine-Mediated Catalytic Hairpin Assembly for Ultrasensitive Detection of MicroRNA
Zhang, X., Yang, Y., Du, S., Kong, L., Chai, Y., Li, Z., & Yuan, R. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c03215 · Cited by 58
Autophagy facilitates age-related cell apoptosis—a new insight from senile cataract
Huang, J., Yu, W., He, Q., He, X., Yang, M. W., Chen, W., & Han, W. (2022) · Cell Death and Disease · doi:10.1038/s41419-021-04489-8 · Cited by 64
“Consequently, the age-related cell loss in postmitotic tissues can contribute to the occurrence of most senescence-associated degenerative diseases, including neurodegenerative Alzheimer’s or Parkinson’s disease [4], cardiomyopathy [5, 6], osteoarthritis [7], and senile cataract [8].”
BackgroundIn vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications
Huang, K. L., Zapata, D. A., Tang, Y., Teng, Y., & Li, Y. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121876 · Cited by 66
Exosome and its roles in cardiovascular diseases
Wang, Z., Zheng, X., & Zhao, S. (2014) · Heart Failure Reviews · doi:10.1007/s10741-014-9469-0 · Cited by 58
“Such complex changes in miRNAs discussed for long-standing cardiovascular diseases are also valid during acute events such as MI [129, 130].”
BackgroundCirculating miR-34a levels correlate with age-related hearing loss in mice and humans
Pang, J., Xiong, H., Yang, H., Ou, Y., Xu, Y., Huang, Q., Lai, L., Chen, S., Zhang, Z., Cai, Y., et al. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.01.009 · Cited by 61
“Previous studies have shown that miR-34a is upregulated in a variety of age-related diseases, including acute myocardial infarction, Alzheimer’s disease, and hearing loss (Abe and Bonini, 2013; Boon et al., 2013; Zhang et al., 2013).”
Emergence of miR-34a in radiation therapy
Lacombe, J., & Zenhausern, F. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.11.017 · Cited by 58
“Thus, miR-34a plays a critical role in the progression of cardiac tissue fibrosis especially by downregulating PNUTS (Boon et al., 2013) and Smad4 pathway (Huang et al., 2014).”
Zuccolo, E., Badi, I., Scavello, F., Gambuzza, I., Mancinelli, L., Macrì, F., Tedesco, C. C., Veglia, F., Bonfigli, A. R., Olivieri, F., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124454 · Cited by 52
“In the heart, genetic deletion of Mir34a reduces the contractile function decline in old mice by inhibiting cardiomyocytes apoptosis [23].”
BackgroundExtracellular Vesicles as Communicators of Senescence in Musculoskeletal Aging
Alfonzo, M. C., Saedi, A. A., Fulzele, S., & Hamrick, M. W. (2022) · JBMR Plus · doi:10.1002/jbm4.10686 · Cited by 64
“Mir-34a is associated with aging and senescence in other tissues, including the heart((28)) and brain,((29)) and is known to target Wnt and Notch pathways, as well as cell survival factors such as Sirt1 and Bcl2.”
BackgroundmiR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma
Bennett, P., Bemis, L., Norris, D. A., & Shellman, Y. G. (2013) · Physiological Genomics · doi:10.1152/physiolgenomics.00116.2013 · Cited by 56
Ooi, J. Y. Y., Bernardo, B. C., Singla, S., Patterson, N. L., Lin, R. C. Y., & McMullen, J. R. (2016) · RNA Biology · doi:10.1080/15476286.2016.1181251 · Cited by 56
“regulatory subunit 10 (PPP1R10; also known as PNUTS), sirtuin 1, Cyclin D1 and B-cell lymphoma 2.(6,7) Here, we were interested”
BackgroundMacromolecular Degradation Systems and Cardiovascular Aging
Nakayama, H., Nishida, K., & Otsu, K. (2016) · Circulation Research · doi:10.1161/circresaha.115.307495 · Cited by 57
“As mentioned above, miR-34a promotes age-related cardiomyocyte cell death and cardiac dysfunction.(137) miR-17-3p diminishes cardiac aging in mice.”
BackgroundInvolvement of PINK1/Parkin-mediated mitophagy in AGE-induced cardiomyocyte aging
Zha, Z., Wang, J., Wang, X., Lu, M., & Guo, Y. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.161 · Cited by 58
Arpón, A., Milagro, F. I., Santos, J. L., García-Granero, M., Riezu-Boj, J.-I., & Martínez, J. A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00496 · Cited by 58
“Moreover, miRNAs have also been involved in aging processes; for example, miR-34a has been described as an aging marker in several tissues and systems since it is upregulated in the aging heart, and its inhibition reduces cell death and fibrosis after an acute myocardial infarction (20).”
Stochastic RNA Walkers for Intracellular MicroRNA Imaging
Xiao, M., Wang, X., Li, L., & Pei, H. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b02265 · Cited by 56
Relevance of microRNA in metabolic diseases
Price, N. L., Ramírez, C. M., & Fernandez-Hernando, C. F. (2014) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2014.937522 · Cited by 59
Hao, J., Zhang, L., Cong, G., Ren, L., & Hao, L. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2469-8 · Cited by 55
“myocardial infarction and age-associated cardiomyocyte cell death (Ito et al. 2010; Boon et al. 2013; Bernardo et al. 2012; Fan et al. 2013).”
BackgroundOwczarz, M., Budzinska, M., Domaszewska-Szostek, A., Borkowska, J., Polosak, J., Gewartowska, M., Slusarczyk, P., & Puzianowska-Kuznicka, M. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217720884 · Cited by 54
“One of its features is the overexpression of miR-34a: this was detected in the cardiac muscle and endothelial cells of aged mice, as well as in the liver and kidneys of aged rats, among others.(60,61) Therefore, the overexpression of this miRNA in PBMC of aging humans described in this work complements existing data.”
ResultJung, J., Ikeda, G., Tada, Y., von Bornstaedt, D., Santoso, M. R., Wahlquist, C., Rhee, S., Jeon, Y.-J., Yu, A. C., O’Brien, C., et al. (2021) · Basic Research in Cardiology · doi:10.1007/s00395-021-00858-8 · Cited by 57
“Furthermore, several miRNAs were identified to regulate the survival of the native cardiomyocytes through enhanced cardiac repair and regeneration [7, 24].”
BackgroundYan, Y., Salazar, T. E., Dominguez, J. M., Nguyen, D. V., Calzi, S. L., Bhatwadekar, A. D., Qi, X., Busik, J. V., Boulton, M. E., & Grant, M. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080029 · Cited by 57
“Several studies demonstrated an important role of miRNA in metabolic regulation[47] and aging[48,49].”
BackgroundExercise training in hypertension: Role of microRNAs
das Neves, V. J., Fernandes, T. M., Roque, F. R., Soci, Ú. P. R., Melo, S. F. S., & de Oliveira, E. M. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i8.713 · Cited by 59
Bonetti, P., Climent, M., Panebianco, F., Tordonato, C., Santoro, A., Marzi, M. J., Pelicci, P. G., Ventura, A., & Nicassio, F. (2018) · Oncogene · doi:10.1038/s41388-018-0445-3 · Cited by 58
Cell type–specific microRNA therapies for myocardial infarction
Liu, B., Wang, B., Zhang, X., Lock, R., Nash, T., & Vunjak-Novakovic, G. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd0914 · Cited by 53
Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR‐34a and miR‐122 Expression
Frères, P., Josse, C., Bovy, N., Boukerroucha, M., Struman, I., Bours, V., & Jérusalem, G. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24730 · Cited by 52
“Boon et al. (2013) demonstrated that miR-34a is involved in fibrosis and cell death following aging and acute myocardial infarction by inhibiting PNUTS (PPP1R10), which normally inhibits telomere shortening and apoptosis in cardiomyocytes.”
BackgroundYe, Z., Fang, J., Dai, S., Wang, Y., Fu, Z., Feng, W., Wei, Q., & Huang, P. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.023 · Cited by 53
Braza‐Boïls, A., Marí‐Alexandre, J., Molina, P., Arnau, M. Á., Barceló‐Molina, M., Domingo, D., Girbés, J., Giner, J., Martínez‐Dolz, L., & Zorio, E. (2016) · Liver International · doi:10.1111/liv.13097 · Cited by 53
“In our cohort, we have found significant correlation between hepatic miR-34a-5p levels and age in the control group, in keeping with previous reports linking high miR-34a levels with the ageing heart (37).”
ResultMicroRNA Signature and Cardiovascular Dysfunction
Arunachalam, G., Upadhyay, R., Ding, H., & Triggle, C. R. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000178 · Cited by 59
Bernardo, B. C., Ooi, J. Y. Y., Matsumoto, A., Tham, Y. K., Singla, S., Kiriazis, H., Patterson, N. L., Sadoshima, J., Obad, S., Lin, R. C. Y., et al. (2016) · The Journal of Physiology · doi:10.1113/jp272512 · Cited by 57
Sources to variability in circulating human miRNA signatures
Keller, A., Rounge, T., Backes, C., Ludwig, N., Gislefoss, R., Leidinger, P., Langseth, H., & Meese, E. (2017) · RNA Biology · doi:10.1080/15476286.2017.1367888 · Cited by 50
“Since miRNA values are also influenced by the age of individuals [21] – not only in body fluids but even in tissues such as the heart [22] – longitudinal monitoring of individuals over time is required.”
BackgroundDing, B., Yang, D., Swendeman, S. L., Christoffersen, C., Nielsen, L. B., Friedman, S. L., Powell, C. A., Hla, T., & Cao, Z. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.05.024 · Cited by 54
“Organ regeneration in most vertebrates is limited by the aging process (Boon et al., 2013; Chen et al., 2016; Conboy et al., 2005; Gurtner et al., 2008; Han et al., 2018; Katsimpardi et al., 2014; Kusumbe et al., 2016; Loffredo et al., 2013; Martinod et al., 2017; Poss, 2010; Rajagopal and Stanger, 2016; Sinha et al.,…”
BackgroundGacoń, J., Kabłak-Ziembicka, A., Stępień, E. Ł., Enguita, F. J., Karch, I., Derlaga, B., Zmudka, K. F., & Przewłocki, T. (2015) · Kardiologia Polska · doi:10.5603/kp.a2015.0174 · Cited by 54
“286 subunit), which inhibits telomere shortening, DNA damage response, and apoptosis, possibly also in cardiomyocytes [21].”
BackgroundmiR-21 suppression prevents cardiac alterations induced by d-galactose and doxorubicin
Bei, Y., Wu, X., Crețoiu, D., Shi, J., Zhou, Q., Lin, S., Wang, H., Cheng, Y., Zhang, H., Xiao, J., et al. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.01.007 · Cited by 56
Zhang, Y., Ding, Y., Li, M., Yuan, J., Yu, Y., Bi, X., Hong, H., Ye, J., & Liu, P. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.020 · Cited by 50
Cardiomyocyte-specific miRNA-30c over-expression causes dilated cardiomyopathy
Wijnen, W. J., van der Made, I., van den Oever, S., Hiller, M., de Boer, B. A., Picavet, D. I., Chatzispyrou, I. A., Houtkooper, R. H., Tijsen, A. J., Hagoort, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096290 · Cited by 48
Counteracting Protein Kinase Activity in the Heart: The Multiple Roles of Protein Phosphatases
Weber, S., Meyer-Roxlau, S., Wagner, M., Dobrev, D., & El‐Armouche, A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00270 · Cited by 56
Non-coding RNAs in cardiac regeneration
Tao, L., Bei, Y., Zhou, Y., Xiao, J., & Li, X. (2015) · Oncotarget · doi:10.18632/oncotarget.6073 · Cited by 54
“com/oncotarget contribute to worse outcomes in patients with MI [72].”
Huang, X., Gao, Y., Qin, J., & Lu, S. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26286 · Cited by 50
“In hearts, miR-34a gene ablation reduces systolic function and prevents cardiac hypertrophy in aged mice through reducing cardiomyocytes apoptosis.(12) Overexpression of miR-34a attenuates the expression of Nrf-2 and its downstream targets.”
BackgroundAssociation between hypertension and circulating vascular-related microRNAs
Hijmans, J. G., Diehl, K. J., Bammert, T. D., Kavlich, P. J., Lincenberg, G. M., Greiner, J. J., Stauffer, B. L., & DeSouza, C. A. (2018) · Journal of Human Hypertension · doi:10.1038/s41371-018-0061-2 · Cited by 53
“In fact, reduction in circulating levels of miR-34a in animal models has been shown to limit ventricular remodeling and cell death and improve cardiac function after myocardial infarction [24].”
BackgroundInfluentialRBFox2-miR-34a-Jph2 axis contributes to cardiac decompensation during heart failure
Hu, J., Gao, C., Wei, C., Xue, Y., Shao, C., Hao, Y., Gou, L., Zhou, Y., Zhang, J., Ren, S. V., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1822176116 · Cited by 53
“Importantly, this set of highly induced miRNAs includes miR-34a, which has been previously linked to both age-linked and pressure–overloading-induced heart failure (6, 7), indicating a potential combinatory mechanism (i.”
BackgroundLong noncoding RNA in cardiac aging and disease
Lozano‐Vidal, N., Bink, D. I., & Boon, R. A. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz046 · Cited by 53
“Telomere attrition has been identified as a risk factor for several CVDs, such as myocardial infarction (Boon et al., 2013; Bar et al., 2014), atrial fibrillation (Staerk et al., 2017), and cardiomyopathy (Leri et al., 2003; Sahin et al., 2011; Sharifi-Sanjani et al., 2017).”
BackgroundSelf-citationSilencing miR-370-3p rescues funny current and sinus node function in heart failure
Yanni, J., D’Souza, A., Wang, Y., Li, N., Hansen, B. J., Zakharkin, S. O., Smith, M., Hayward, C. E., Whitson, B. A., Mohler, P. J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-67790-0 · Cited by 53
Small extracellular vesicle-mediated CRISPR-Cas9 RNP delivery for cardiac-specific genome editing
Mun, D., Kang, J., Kim, H., Yun, N., & Joung, B. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.05.023 · Cited by 53
miR-27a-5p Attenuates Hypoxia-induced Rat Cardiomyocyte Injury by Inhibiting Atg7
Zhang, J., Qiu, W., Ma, J., Wang, Y., Hu, Z., Long, K., Wang, X., Jin, L. G., Tang, Q., Tang, G., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102418 · Cited by 50
“To investigate whether the miR-27a-5p expression under hypoxia induced by AMI in vivo was similar to that in hypoxia-exposed cardiomyocytes in vitro, an AMI rat model was established by ligating the coronary artery [16].”
MethodGao, H., Ren, F., Wen, P., Xie, L. X., Wang, R., Yang, Z. N., & Li, Y. X. (2020) · Journal of Dairy Science · doi:10.3168/jds.2020-19063 · Cited by 50
Epigenetic regulation in heart failure
Kim, S. Y., Morales, C. R., Gillette, T. G., & Hill, J. A. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000276 · Cited by 51
The Roles of microRNAs in the Cardiovascular System
Nappi, F., Singh, S., Jitendra, V., Alzamil, A., & Schoell, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814277 · Cited by 52
MicroRNAs in cardiovascular ageing
Seeger, T., & Boon, R. A. (2015) · The Journal of Physiology · doi:10.1113/jp270557 · Cited by 53
“…member in cardiomyocytes and the increased miR-34a expression in the aged heart is probably due to an increase in p53 signalling, known to be induced in ageing. miR-34 family members induce apoptosis during ageing, but also after acute myocardial infarction (Bernardo et al. 2012; Boon et al. 2013).”
BackgroundSelf-citationRole of redoximiRs in fibrogenesis
Fierro‐Fernández, M., Miguel, V., & Lamas, S. (2015) · Redox Biology · doi:10.1016/j.redox.2015.11.006 · Cited by 52
“The expression of miR-21 is increased in experimental fibrosis and importantly in patients with IPF [171] and miR-21 up-regulation was proportional to the severity of lung fibrosis in the bleomycin mouse model.”
BackgroundGreen, C. D., Huang, Y., Dou, X., Yang, L., Liu, Y., & Han, J.-D. J. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.001 · Cited by 47
Haas, J., Mester, S., Lai, A., Frese, K., Sedaghat‐Hamedani, F., Kayvanpour, E., Rausch, T., Nietsch, R., Boeckel, J., Carstensen, A., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707838 · Cited by 51
“The myocardium has to permanently adapt to changes in the hemodynamic demand (Heusch et al, 2014), aging of the organism (Boon et al, 2013), and multiple external stressors (Ware et al, 2016).”
BackgroundSelf-citationAdding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach
Marracino, L., Fortini, F., Bouhamida, E., Camponogara, F., Severi, P., Mazzoni, E., Patergnani, S., D’Aniello, E., Campana, R., Pinton, P., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.695114 · Cited by 50
Sheikh, M. S. A., Xia, K., Li, F., Deng, X., Salma, U., Deng, H., Wei, L. W., Yang, T., & Peng, J. (2015) · BioMed Research International · doi:10.1155/2015/740301 · Cited by 48
“Recently, it has been demonstrated that miRNAs have significant association with ageing heart [40, 41].”
BackgroundLinhares‐Lacerda, L., Granato, A., Gomes-Neto, J. F., Conde, L., Freire‐de‐Lima, L., de Freitas, E. O., Freire-de-Lima, C. G., Barroso, S. P. C., Guerra, R. J. D. A., Pedrosa, R. C., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00269 · Cited by 47
“In degenerative cardiovascular diseases, microRNAs (miRNAs) are crucial regulators of cardiac function (Filipowicz et al., 2008; Boon et al., 2013).”
BackgroundLock, M. C., Tellam, R. L., Botting, K. J., Wang, K. C. W., Selvanayagam, J. B., Brooks, D. A., Seed, M., & Morrison, J. L. (2018) · The Journal of Physiology · doi:10.1113/jp276072 · Cited by 51
Rational Engineering of a Dynamic, Entropy‐Driven DNA Nanomachine for Intracellular MicroRNA Imaging
Liang, C., Ma, P., Liu, H., Guo, X., Yin, B., & Ye, B. (2017) · Angewandte Chemie · doi:10.1002/ange.201704147 · Cited by 47
Cardiac Physiology of Aging: Extracellular Considerations
Horn, M. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140063 · Cited by 48
Administration of MicroRNA-210 Promotes Spinal Cord Regeneration in Mice
Ujigo, S., Kamei, N., Hadoush, H., Fujioka, Y., Miyaki, S., Nakasa, T., Tanaka, N., Nakanishi, K., Eguchi, A., Sunagawa, T., et al. (2014) · Spine · doi:10.1097/brs.0000000000000356 · Cited by 47
miRNAs in stem cell aging and age-related disease
Choi, S. W., Lee, J. Y., & Kang, K. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.08.013 · Cited by 62
Gómez-Verján, J. C., Vázquez-Martínez, E. R., Rivero-Segura, N. A., & Medina-Campos, R. H. (2018) · Human Genetics · doi:10.1007/s00439-018-1955-3 · Cited by 48
Dynamic monitoring of oxidative DNA double-strand break and repair in cardiomyocytes
Ye, B., Hou, N., Xiao, L., Xu, Y., Xu, H., & Li, F. (2015) · Cardiovascular Pathology · doi:10.1016/j.carpath.2015.10.010 · Cited by 50
“Many factors including microRNA can modulate DDR in CMs [38].”
BackgroundNoncoding RNAs in Heart Failure
Dangwal, S., Schimmel, K., Foinquinos, A., Xiao, K., & Thum, T. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_99 · Cited by 46
“Recent studies suggest their exceptional ability to regulate bidirectional gene expression at any level by controlling chromatin methylation, histone modifications, mRNA transcription, stability or translation, etc. (Boon et al. 2013;Quiat andOlson 2013; Thum2012).”
BackgroundCardioprotective effects of miR-34a silencing in a rat model of doxorubicin toxicity
Piegari, E., Cozzolino, A., Ciuffreda, L. P., Cappetta, D., Angelis, A. D., Urbanek, K., Rossi, F., & Berrino, L. (2020) · Scientific Reports · doi:10.1038/s41598-020-69038-3 · Cited by 45
Anti-ageing interventions for the treatment of cardiovascular disease
Abdellatif, M., Schmid, S., Fuerlinger, A., & Kroemer, G. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae177 · Cited by 52
“25,26 This elevated expression of microRNA-34a has been correlated with DNA damage and senescence, 26,27 whereas its inhibition in male mice improved age-related cardiac decline, accentuated vascular calcification, cardiac recovery from ischaemic injury and pathological cardiac remodelling induced…”
Harnessing the microRNA pathway for cardiac regeneration
Giacca, M., & Zacchigna, S. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.09.017 · Cited by 45
Molecular Aspects of Exercise-induced Cardiac Remodeling
Bernardo, B. C., & McMullen, J. R. (2016) · Cardiology Clinics · doi:10.1016/j.ccl.2016.06.002 · Cited by 51
MicroRNA-449c-5p inhibits osteogenic differentiation of human VICs through Smad4-mediated pathway
Xu, R., Zhao, M., Yang, Y., Huang, Z., Shi, C., Hou, X., Zhao, Y., Chen, B., Xiao, Z., Liu, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09390-z · Cited by 46
Chen, G.-H., Xu, C., Zhang, J., Li, Q., Cui, H., Li, X., Chang, L., Tang, R., Xu, J., Tian, X., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00775 · Cited by 44
“…for our in vitro experiments, we used human cardiomyocytes, which are widely employed in cardiovascular research (Albrecht-Schgoer et al., 2012; Boon et al., 2013; Baker et al., 2015; Kuo et al., 2015; Nehra et al., 2015; Sharma et al., 2015), rather than cardiomyocytes isolated from animals.”
MethodTelomere length as a potential biomarker of coronary artery disease
Bhattacharyya, J., Mihara, K., Bhattacharjee, D., & Mukherjee, M. (2017) · Indian Journal of Medical Research · doi:10.4103/0971-5916.216974 · Cited by 42
MicroRNA-135a inhibits cardiac fibrosis induced by isoproterenol via TRPM7 channel
Wu, Y. L., Liu, Y., Pan, Y., Lu, C., Xu, H., Wang, X., Liu, T., Feng, K., & Tang, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.157 · Cited by 44
Pi, C., Ma, C., Wang, H., Sun, H., Yu, X., Gao, X., Yang, Y. J., Sun, Y., Zhang, H., Shi, Y., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02339-0 · Cited by 49
“In addition, ample evidences have confirmed elevated miR-34a levels were induced in various cells, tissues, and organs, including senescent endothelial progenitor cells (EPCs), lung myofibroblasts in both human and mouse [32], hearts of aged mice [15], and liver, kidney, and brain of old rats [33–35].”
BackgroundResultThe Impact of microRNAs in Renin–Angiotensin-System-Induced Cardiac Remodelling
Adamcová, M., Kawano, I., & Šimko, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094762 · Cited by 46
M i R ‐34a deficiency accelerates medulloblastoma formation in vivo
Thor, T., Künkele, A., Pajtler, K. W., Wefers, A. K., Stephan, H., Mestdagh, P., Heukamp, L. C., Hartmann, W., Vandesompele, J., Sadowski, N., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29294 · Cited by 44
“found reduced age-associated decline in cardiac function in miR-34a deficient mice.(19) Taken together, our comprehensive phenotypic screen corroborates and extends previous reports and strongly points to a nonessential role of miR-34a in normal murine development.”
ResultFu, B., Lang, J., Zhang, D., Sun, L., Chen, W., Liu, W., Liu, K.-Y., Ma, C., Jiang, S., Li, R., et al. (2017) · Stem Cells and Development · doi:10.1089/scd.2017.0062 · Cited by 43
“…research has shown that knockout of microRNA-34a (miR-34a) in the heart can lessen MI injury, attenuate vessel damage under oxidative stress, and regulate the microenvironment by increasing the expression of downstream genes PPP1R10 (PNUTS) and silent information regulator 1 (SIRT1) [9,10].”
Epigenetics and cardiovascular regenerative medicine in the elderly
Costantino, S., Camici, G. G., Mohammed, S. A., Volpe, M., Lüscher, T. F., & Paneni, F. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.09.188 · Cited by 45
Sarkar, S. N., Russell, A. E., Engler-Chiurazzi, E. B., Porter, K. N., & Simpkins, J. W. (2018) · Aging and Disease · doi:10.14336/ad.2018.0409 · Cited by 45
“In the aging heart [40] and in AD patients’ brain [41], increased expression of miR-34a and miR-146a has been reported.”
BackgroundLi, X., Sun, Y., Huang, S., Chen, Y., Chen, X., Li, M., Si, X., He, X. F., Zheng, H., Zhong, L., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.001 · Cited by 44
“Many studies have explored ncRNAs that promote CM regeneration in terms of cell cycle re-entry [6], CM apoptosis reduction [7] and heart ageing delay [8].”
BackgroundNoncoding RNAs Controlling Telomere Homeostasis in Senescence and Aging
Rossi, M. S., & Gorospe, M. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.01.010 · Cited by 51
“PNUTS was previously found to inhibit the DDR and to interact with TRF2, further preventing telomere shortening [41, 42].”
BackgroundMicroRNAs in Cancer and Cardiovascular Disease
Ilieva, M. S., Panella, R., & Uchida, S. (2022) · Cells · doi:10.3390/cells11223551 · Cited by 48
“Because ageing is a hot topic to be investigated, subsequent research shows the functional importance of miR-34a in cell types other than endothelial cells in the heart, including in cardiomyocytes [79,80], fibroblasts [81], and smooth muscle cells [82,83].”
BackgroundZhong, Z., Gao, Y., Zhou, J., Wang, F., Zhang, P., Hu, S., Wu, H., Lou, H., Chi, J., Lin, H., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115654 · Cited by 44
Protein Electrocatalysis for Direct Sensing of Circulating MicroRNAs
Labib, M., Khan, N., & Berezovski, M. V. (2014) · Analytical Chemistry · doi:10.1021/ac504331c · Cited by 44
Deng, S., Wang, H., Jia, C., Zhu, S., Chu, X., Ma, Q., Wei, J., Chen, E., Zhu, W., Macon, C. J., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308378 · Cited by 43
MiR-532-5p alleviates hypoxia-induced cardiomyocyte apoptosis by targeting PDCD4
Ma, J., Zhang, J., Wang, Y., Long, K., Wang, X., Jin, L. G., Tang, Q., Zhu, L., Tang, G., Li, X., et al. (2018) · Gene · doi:10.1016/j.gene.2018.06.087 · Cited by 44
Sun, J., Cui, F., Zhang, R., Gao, Z., Ji, J., Ren, Y., Pi, F., Zhang, Y., & Sun, X. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b02854 · Cited by 43
MicroRNA‐574 regulates FAM210A expression and influences pathological cardiac remodeling
Wu, J., Subbaiah, K. C. V., Jiang, F., Hedaya, O. M., Mohan, A. M., Yang, T., Welle, K. A., Ghaemmaghami, S., Tang, W. H. W., Small, E. M., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012710 · Cited by 46
“…to pathological cardiac remodeling, which included the cardiac tissues of patients during the initial stages following MI onset (Bostjancic et al , 2009), a mouse model of left coronary artery occlusion-derived MI (van Rooij et al , 2006), and aged murine hearts (Fig 1A) (Boon et al , 2013).”
Khidr, E. G., Abulsoud, A. I., Doghish, A. A., El‐Mahdy, H. A., Ismail, A. M. A., Elballal, M. S., Sarhan, O. M., Mageed, S. S. A., Elsakka, E. G. E., Elkhawaga, S. Y., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154624 · Cited by 43
Metadata
- Authors
- Boon, R. A., Iekushi, K., Lechner, S., Seeger, T., Fischer, A., Heydt, S., Kaluza, D., Tréguer, K., Carmona, G., Bonauer, A., Horrevoets, A. J. G., Didier, N., Girmatsion, Z., Biliczki, P., Ehrlich, J. R., Katus, H. A., Müller, O. J., Potente, M., Zeiher, A. M., Hermeking, H., & Dimmeler, S.
- Affiliations
- Goethe University Frankfurt (DE)
- Pathologisches Institut (DE)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Inserm (FR)
- Heidelberg University (DE)
- Corresponding author
- Dimmeler, Stefanie
- ORCID
- Venue
- Nature
- Published
- 2013-02-20
- Volume
- 495
- Issue
- 7439
- Pages
- 107-110
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2090374150
- Cited by
- 821
- References
- 36
- Citations by year
- 2026: 29 · 2025: 37 · 2024: 41 · 2023: 42 · 2022: 64 · 2021: 45 · 2020: 61 · 2019: 59 · 2018: 72 · 2017: 84 · 2016: 75 · 2015: 85 · 2014: 90 · 2013: 34
- FWCI
- 33.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- miR-34a, cardiac aging, PNUTS, microRNA regulation, cardiomyocyte apoptosis, telomere shortening, DNA damage response, myocardial fibrosis, acute myocardial infarction, cardiac contractile function, therapeutic target
- MeSH terms
- Aging, Animals, DNA Damage, Fibrosis, Gene Expression Regulation, Heart, Mice, Inbred C57BL, Myocardial Infarction, Myocardium, Substrate Specificity, Genetic Therapy, Telomere, Apoptosis, Gene Deletion, Myocytes, Cardiac, MicroRNAs, Mice, Gene Knockout Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.